METASTATIC BILIARY TRACT CANCER
Clinical trials for METASTATIC BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to fight tough bile duct cancer
Disease control Recruiting nowThis early-phase trial tests whether adding an experimental drug called CTX-009 to standard chemotherapy (gemcitabine and cisplatin) plus immunotherapy (durvalumab) can safely treat advanced biliary tract cancer that cannot be removed by surgery. About 50 adults will receive the …
Matched conditions: METASTATIC BILIARY TRACT CANCER
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New drug cocktail aims to boost bile duct cancer treatment
Disease control Recruiting nowThis early-phase trial tests a new drug called emavusertib added to standard chemotherapy and immunotherapy for people with untreated advanced bile duct cancer. The goal is to see if the combination is safe and to find the best dose. About 48 participants will be enrolled.
Matched conditions: METASTATIC BILIARY TRACT CANCER
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC